Point72 Hong Kong’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-22
Closed -$4K 226
2022
Q3
$4K Sell
22
-213
-91% -$38.7K ﹤0.01% 1274
2022
Q2
$50K Buy
+235
New +$50K ﹤0.01% 928
2021
Q4
Sell
-224
Closed -$109K 1373
2021
Q3
$109K Buy
+224
New +$109K ﹤0.01% 716
2021
Q2
Sell
-33
Closed -$23K 1386
2021
Q1
$23K Buy
+33
New +$23K ﹤0.01% 929
2020
Q4
Sell
-127
Closed -$88K 1278
2020
Q3
$88K Buy
+127
New +$88K 0.01% 579
2020
Q1
Sell
-96
Closed -$22K 980
2019
Q4
$22K Buy
96
+51
+113% +$11.7K 0.01% 853
2019
Q3
$5K Buy
+45
New +$5K ﹤0.01% 806
2018
Q4
Sell
-28
Closed -$3K 904
2018
Q3
$3K Hold
28
﹤0.01% 732
2018
Q2
$4K Sell
28
-359
-93% -$51.3K ﹤0.01% 717
2018
Q1
$63K Buy
+387
New +$63K 0.03% 410